The authors of “Human Epidermal Growth Factor Receptor 2–Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer” include Ali Alhuseinalkhudhur, Division of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden, and Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden; Henrik Lindman and Vladimir Tolmachev, Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden; Per Liss, Division of Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Tora Sundin, Clinical Research and Development Unit, Uppsala University Hospital, Uppsala, Sweden; Fredrik Y. Frejd, Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden, and Affibody AB, Solna, Sweden; Johan Hartman and Caroline Rönnlund, Department of Oncology–Pathology, Karolinska Institute, Stockholm, Sweden, and Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden; Victor Iyer, Irina Velikyan, and Jens Sörensen, Division of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Joachim Feldwisch, Affibody AB, Solna, Sweden; and Mark Lubberink, Division of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden, and Department of Medical Physics, Uppsala University Hospital, Uppsala, Sweden.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or [email protected].
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.